What does Orgenesis, Inc. do?

Jun 22 2025 06:34 PM IST
share
Share Via
Orgenesis, Inc. is a biopharmaceutical company specializing in cell and gene therapy technologies and services. As of September 2024, it reported net sales of $0 million and a net loss of $9 million, with a market cap of $9.98 million.
Overview:
Orgenesis, Inc. is a biopharmaceutical company operating in the Pharmaceuticals & Biotechnology industry, focused on developing, manufacturing, and processing technologies and services in the cell and gene therapy sector.

Financial Snapshot:
Most recent Net Sales: 0 Million (Quarterly Results - Sep 2024)
Most recent Net Profit: -9 Million (Quarterly Results - Sep 2024)
Market cap: USD 9.98 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.60
Return on Equity: 121.55%
Price to Book: -0.42

Contact Details:
Address: 20271 Goldenrod Ln, Germantown MD: 20876-4064
Tel: 1 480 6596404
Website: https://www.orgenesis.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Orgenesis, Inc. technically bullish or bearish?
Sep 20 2025 07:35 PM IST
share
Share Via
Is Orgenesis, Inc. overvalued or undervalued?
Jun 25 2025 08:48 AM IST
share
Share Via
Is Orgenesis, Inc. technically bullish or bearish?
Jun 25 2025 08:41 AM IST
share
Share Via
Who are in the management team of Orgenesis, Inc.?
Jun 22 2025 10:24 PM IST
share
Share Via
How big is Orgenesis, Inc.?
Jun 22 2025 05:55 PM IST
share
Share Via